TNF and inflammatory bowel disease: Eriksson et al. [28] reported no significant differences in efficacy between sexes in a real-life Swedish cohort of 246 IBD patients (37.3% with UC) treated with VDZ, the vast majority of whom were anti-TNF-exposed.